Trial intelligence / Profile preview

Peri-operative high-dose intravenous dexamethasone in direct anterior total hip arthroplasty

2019-004834-40Phase 4Completed

Sponsor
UZ Leuven
Start
Apr 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in hip osteoarthritis and osteonecrosis of the hip comparing High-dose intravenous dexamethasone with Placebo (2 arms). Primary endpoint: Average number of steps. Started Apr 2020; status: completed.

02

Drugs

dexamethasone
03

Conditions

hip osteoarthritisosteonecrosis of the hip

Beyond the preview

Go deeper on 2019-004834-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-004834-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call